[go: up one dir, main page]

DE69105114D1 - Methode zur erhöhung der fruchtbarkeit weiblicher säuger. - Google Patents

Methode zur erhöhung der fruchtbarkeit weiblicher säuger.

Info

Publication number
DE69105114D1
DE69105114D1 DE69105114T DE69105114T DE69105114D1 DE 69105114 D1 DE69105114 D1 DE 69105114D1 DE 69105114 T DE69105114 T DE 69105114T DE 69105114 T DE69105114 T DE 69105114T DE 69105114 D1 DE69105114 D1 DE 69105114D1
Authority
DE
Germany
Prior art keywords
fertility
increasing
female mammals
mammal
female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69105114T
Other languages
English (en)
Other versions
DE69105114T2 (de
Inventor
Teresa Woodruff
Jennie Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69105114D1 publication Critical patent/DE69105114D1/de
Application granted granted Critical
Publication of DE69105114T2 publication Critical patent/DE69105114T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Photolithography (AREA)
  • Containers, Films, And Cooling For Superconductive Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Fluid-Pressure Circuits (AREA)
DE69105114T 1990-01-08 1991-01-04 Methode zur erhöhung der fruchtbarkeit weiblicher säuger. Expired - Lifetime DE69105114T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46171390A 1990-01-08 1990-01-08
PCT/US1991/000079 WO1991010445A1 (en) 1990-01-08 1991-01-04 Method for increasing fertility in females

Publications (2)

Publication Number Publication Date
DE69105114D1 true DE69105114D1 (de) 1994-12-15
DE69105114T2 DE69105114T2 (de) 1995-05-04

Family

ID=23833651

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69105114T Expired - Lifetime DE69105114T2 (de) 1990-01-08 1991-01-04 Methode zur erhöhung der fruchtbarkeit weiblicher säuger.

Country Status (9)

Country Link
EP (1) EP0509040B1 (de)
JP (1) JPH05503699A (de)
AT (1) ATE113842T1 (de)
AU (1) AU638310B2 (de)
CA (1) CA2069755A1 (de)
DE (1) DE69105114T2 (de)
DK (1) DK0509040T3 (de)
ES (1) ES2065673T3 (de)
WO (1) WO1991010445A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
AU722150B2 (en) * 1997-03-06 2000-07-20 University Of Adelaide, The Treatment and diagnosis of infertility using TGFbeta or activin
AUPO550897A0 (en) * 1997-03-06 1997-03-27 Luminis Pty Limited Treatment and diagnosis of an infertility condition
AUPO638897A0 (en) * 1997-04-23 1997-05-22 Monash University Modulation of cell growth and methods relating thereto
YU81600A (sh) 1998-06-22 2004-03-12 Medi-Cult A/S. Ispitivanje za ukazivanje na prisustvo jajnih ćelija koje se ne mogu oploditi
WO2000050638A1 (en) * 1999-02-25 2000-08-31 Auckland Uniservices Limited Diagnosis and therapy of premature ovarian failure
BR102014005376A2 (pt) * 2014-03-07 2016-02-10 Ouro Fino Saúde Animal Ltda antígeno de inibina alfa, gene codificante de inibina alfa, gene codificante de proteína de fusão, processo de obtenção do antígeno de inibina alfa, composição antigênica, uso do antígeno de inibina alfa e uso da composição antigênica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341617C (en) * 1984-06-08 2011-06-28 Henry George Burger Inhibin isolated from ovarian follicular fluid
US4737578A (en) * 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
WO1988000208A1 (en) * 1986-06-24 1988-01-14 The Salk Institute For Biological Studies Ovine inhibin

Also Published As

Publication number Publication date
WO1991010445A1 (en) 1991-07-25
EP0509040B1 (de) 1994-11-09
EP0509040A1 (de) 1992-10-21
DK0509040T3 (da) 1995-04-18
DE69105114T2 (de) 1995-05-04
AU7173491A (en) 1991-08-05
ES2065673T3 (es) 1995-02-16
JPH05503699A (ja) 1993-06-17
AU638310B2 (en) 1993-06-24
CA2069755A1 (en) 1991-07-09
ATE113842T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
FI880267A7 (fi) Instrumentti keinosiemennystä, alkionsiirtoa tai munarakkulan nesteiden näytteenottoa varten nisäkkäissä.
ATE140868T1 (de) Steigerung der fruchtbarkeit
BR8507081A (pt) Base de construcao para um jogo construtor de brinquedos
ATE113842T1 (de) Methode zur erhöhung der fruchtbarkeit weiblicher säuger.
CO4910140A1 (es) Intermediarios y proceso para preparar olanzapina
ES528703A0 (es) Procedimiento para preparar derivados de prolina disustituidos
ES2029697T3 (es) Fregadero y metodo para su fabricacion.
MX172953B (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica
MA19362A1 (fr) Procede pour preparer enzymatiquement l'acide amino ii methyl phosphino - 4 butyrique -(l) .
ATE106464T1 (de) Hebelitze.
SE503436C2 (sv) Pyroglutamidderivat
DE69100376D1 (de) Verfahren zur hemmung der follikelreifung.
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
PE2591A1 (es) Composicion y metodo para reducir la afliccion gastrointestinal debido a azucares que contienen alfa-d-galactosidos
BR8800365A (pt) Acoplamento de rapido desconjugar para linha de vazao
DK317285A (da) Farmakologisk virksomme (pyrrol-1-yl)-phenyl-dihydropyridazinoner ogfremgangsmaade til fremstilling heraf
DK0472534T3 (da) Somatotropin til forøgelse af fertiliteten hos dyr
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
PT97130A (pt) Processo para a preparacao de beta-cetoesteres uteis na preparacao de antibioticos quinolona
PT86619A (pt) Process for preparing alkylmelatonins
PT89303A (pt) Processo para a preparacao de tienotriciclos e de composicoes farmaceuticas que os contem
BR8107329A (pt) Composicao de lubrificante e processo para sua preparacao camara para cura de pneu e seu processo de tratamento processo de moldagem de um pneu
ES2061718T3 (es) Utilizacion de antigestagenos para la preparacion de medicamentos.
ES2147863T3 (es) Nuevos procedimientos para preparar intermediarios de inhibidores del enzima conversor de la encefalinasa y de la angiotensina y sus intermediarios.
MX6943E (es) Procedimiento para preparar ureidobencilpenicilinas alfa-substituidas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition